IP Considerations Following FDA Announcement on Flexibility for Cell and Gene Therapies
Key Takeaways: Manufacturing processes of cell and gene therapies (CGTs) may remain fluid well into development and even after FDA approval, and therefore sponsors of CGTs may benefit from patent...
Emergence of Satellite Energy Stealth Startup and the Importance of IP Strategy
Key Takeaway: A startup in satellite energy transmission emerged from stealth with an oversubscribed seed round of $10 million. Investors and developers of energy technologies can benefit from proactive IP...
Knobbe Martens Provides IP Counsel to Masimo in Definitive Agreement To Be Acquired by Danaher
IRVINE, Calif., February 17, 2026 – Masimo Corporation, a leading global medical device innovator, today announced that it has entered into a definitive agreement pursuant to which Danaher Corporation will...